Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.06 USD | +2.91% | -0.93% | -73.30% |
04-05 | China SXT Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended September 30, 2023 | CI |
02-08 | Wall Street Set to Open Flat Wednesday; Jobless Claims Fall More Than Expected | MT |
Sales 2022 | 2.6M 3.58M | Sales 2023 | 1.97M 2.71M | Capitalization | 2.96M 4.08M |
---|---|---|---|---|---|
Net income 2022 | -5M -6.88M | Net income 2023 | -5M -6.88M | EV / Sales 2022 | 2.71 x |
Net cash position 2022 | 4.33M 5.96M | Net cash position 2023 | 8.41M 11.57M | EV / Sales 2023 | -2.76 x |
P/E ratio 2022 |
-1.02
x | P/E ratio 2023 |
-0.32
x | Employees | 78 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.99% |
1 day | +2.91% | ||
1 week | -0.93% | ||
1 month | -36.90% | ||
3 months | -45.36% | ||
6 months | -50.70% | ||
Current year | -73.30% |
Managers | Title | Age | Since |
---|---|---|---|
Feng Zhou
CEO | Chief Executive Officer | 32 | 17-07-03 |
Xiaodong Pan
DFI | Director of Finance/CFO | - | 22-01-30 |
Peter Chan
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Feng Zhou
CEO | Chief Executive Officer | 32 | 17-07-03 |
Jun Zheng
BRD | Director/Board Member | 47 | 18-12-30 |
Xiaodong Ji
BRD | Director/Board Member | 54 | 21-05-21 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 1.06 | +2.91% | 186,719 |
24-04-29 | 1.03 | -1.90% | 345,643 |
24-04-26 | 1.05 | +1.94% | 203,439 |
24-04-25 | 1.03 | -3.74% | 142,837 |
24-04-24 | 1.07 | -.--% | 393,012 |
Delayed Quote Nasdaq, April 30, 2024 at 04:00 pm
More quotes1st Jan change | Capi. | |
---|---|---|
-73.30% | 772K | |
+34.00% | 704B | |
+27.72% | 577B | |
-7.75% | 348B | |
+18.53% | 327B | |
+4.95% | 288B | |
+14.92% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.89% | 147B |
- Stock Market
- Equities
- SXTC Stock